ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
58 hedge funds and large institutions have $9.31M invested in Oncternal Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Holders
58
Holding in Top 10
–
Calls
$28K
Puts
$1K
Top Buyers
| 1 | +$575K | |
| 2 | +$268K | |
| 3 | +$54.4K | |
| 4 |
BC
BIT Capital
Berlin,
Germany
|
+$43.1K |
| 5 |
WCA
Waypoint Capital Advisors
Minneapolis,
Minnesota
|
+$38.3K |
Top Sellers
| 1 | -$739K | |
| 2 | -$181K | |
| 3 | -$88.2K | |
| 4 |
Two Sigma Advisers
New York
|
-$80.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$48K |